drugset / Trial / NCT01774760

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

NCT01774760 ↗

Phase 2 Completed 10 enrolled Turku University Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

The results of previous studies suggest further development of \[18F\]EF5 as a PET tracer for imaging hypoxia. This is a non-randomized prospective study to obtain information on reproducibility of \[18F\]EF5 intratumor distribution using repeated pretreatment PET/CT scans.

Timeline

Start
2013-03
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-EF5 Diagnostic / imaging agent 250 mbq Intravenous
Subject 18F-EF5 Diagnostic / imaging agent 350 mbq Intravenous